Exact Mass: 464.1515
Exact Mass Matches: 464.1515
Found 201 metabolites which its exact mass value is equals to given mass value 464.1515
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bexagliflozin
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor D007004 - Hypoglycemic Agents
Armillarinin
Armillarinin is found in mushrooms. Armillarinin is a metabolite of Armillaria mellea (honey mushroom Metabolite of Armillaria mellea (honey mushroom). Armillarinin is found in mushrooms.
Asulacrine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
Sibenadet
2-O-Acetyl-3-O-(2,4-dimethoxy-6-methylbenzoyl)uridine
Me glycoside,tetra-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose
1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-galactopyranosyloxy-5-hydroxy-3,4-dimethoxy-benzene|pungen A
1-O-[alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranosyl]-4-hydroxy-3,5-dimethoxyphenol|rhyncoside B
4-hydroxy-3-methoxyphenyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
2,6-dimethoxy-p-hydroquinone 1-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
4-O-beta-D-glucopyranosyl-2-methoxy-9-phenyl-1H-phenalen-1-one
dichotomine J|methyl 1-[(1R)-1,2-dihydroxyethyl]-8-(beta-D-glucopyranosyloxy)-9H-beta-carboline-3-carboxylate
6-(oxymethyl)-2-hydroxyphenyl-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranoside
3,4-dimethoxy-5-hydroxyphenyl beta-D-apiofuranosyl(1?6)-beta-D-glucopyranoside|cinnacassoside C
1,4-di-O-beta-D-gIucopyranosyloxy-2-methoxybenzene
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid
C19H28O13_4-Hydroxy-3,5-dimethoxyphenyl 6-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranoside
C21H24N2O10_Uridine, 2-acetate 3-(2,4-dimethoxy-6-methylbenzoate)
C19H28O13_5-Hydroxy-2,3-dimethoxyphenyl 4-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranoside
[(2R,3R,4R,5R)-4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid [IIN-based: Match]
[(2R,3R,4R,5R)-4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate_major
Ala Asp Glu Met
Ala Asp Met Glu
Ala Glu Asp Met
Ala Glu Met Asp
Ala Met Asp Glu
Ala Met Glu Asp
Cys Asp Asp Ile
Cys Asp Asp Leu
Cys Asp Glu Val
Cys Asp Ile Asp
Cys Asp Leu Asp
Cys Asp Val Glu
Cys Glu Asp Val
Cys Glu Val Asp
Cys Ile Asp Asp
Cys Leu Asp Asp
Cys Val Asp Glu
Cys Val Glu Asp
Asp Ala Glu Met
Asp Ala Met Glu
Asp Cys Asp Ile
Asp Cys Asp Leu
Asp Cys Glu Val
Asp Cys Ile Asp
Asp Cys Leu Asp
Asp Cys Val Glu
Asp Asp Cys Ile
Asp Asp Cys Leu
Asp Asp Ile Cys
Asp Asp Leu Cys
Asp Glu Ala Met
Asp Glu Cys Val
Asp Glu Met Ala
Asp Glu Val Cys
Asp Ile Cys Asp
Asp Ile Asp Cys
Asp Leu Cys Asp
Asp Leu Asp Cys
Asp Met Ala Glu
Asp Met Glu Ala
Asp Val Cys Glu
Asp Val Glu Cys
Glu Ala Asp Met
Glu Ala Met Asp
Glu Cys Asp Val
Glu Cys Val Asp
Glu Asp Ala Met
Glu Asp Cys Val
Glu Asp Met Ala
Glu Asp Val Cys
Glu Glu Gly Met
Glu Glu Met Gly
Glu Gly Glu Met
Glu Gly Met Glu
Glu Met Ala Asp
Glu Met Asp Ala
Glu Met Glu Gly
Glu Met Gly Glu
Glu Val Cys Asp
Glu Val Asp Cys
Gly Glu Glu Met
Gly Glu Met Glu
Gly Met Glu Glu
Ile Cys Asp Asp
Ile Asp Cys Asp
Ile Asp Asp Cys
Leu Cys Asp Asp
Leu Asp Cys Asp
Leu Asp Asp Cys
Met Ala Asp Glu
Met Ala Glu Asp
Met Asp Ala Glu
Met Asp Glu Ala
Met Glu Ala Asp
Met Glu Asp Ala
Met Glu Glu Gly
Met Glu Gly Glu
Met Gly Glu Glu
Val Cys Asp Glu
Val Cys Glu Asp
Val Asp Cys Glu
Val Asp Glu Cys
Val Glu Cys Asp
Val Glu Asp Cys
Armillarinin
1H-Pyrrolo[2,3-b]pyridine, 3-(3-furanyl)-1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
Sibenadet
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
2,3-O-(1-Methylethylidene)-1-O-(phenylmethyl)-alpha-L-sorbofuranose 6-(4-methylbenzenesulfonate)
Pirlimycin Hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Ethyl 4-{[2-(4-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-7-yl]carbonyl}piperazine-1-carboxylate
2-[3-(2-furanylmethyl)-4-imino-6,6-dimethyl-2-oxo-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-1-yl]-N-phenylacetamide
5-ethyl-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
2-[[3-(benzenesulfonyl)-1-oxopropyl]amino]-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester
N-[(4-fluorophenyl)methyl]-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(2-methylphenyl)benzamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(4-methylphenyl)benzamide
5-(4-Ethoxy-3-methoxyphenyl)-4-(3-methoxybenzoyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(3-methylphenyl)benzamide
Asulacrine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
PLX7922
PLX7922, a RAF inhibitor, can bind with BRAFV600E. PLX7922 inhibits pERK in BRAFV600E cell lines, and activates pERK in mutant NRAS cell lines[1].